| 800848 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Delivery of CD47 blocker SIRPα-Fc by CAR-T cells enhances antitumor efficacy |
2022-02-01 |
10.1136/jitc-2021-003737 |
Chen Huanpeng, Yang Yuying, Deng Yuqing, Wei Fengjiao, Zhao Qingyu, Liu Yongqi, Liu Zhonghua, Yu Bolan, Huang Zhaofeng |
| 800847 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer |
2022-02-01 |
10.1136/jitc-2021-004047 |
Zhang Puran, Gu Yun, Fang Hanji, Cao Yifan, Wang Jieti, Liu Hao, Zhang Heng, Li He, He Hongyong, Li Ruochen, Lin Chao, Xu Jiejie |
| 800846 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1 |
2022-02-01 |
10.1136/jitc-2020-001698corr2 |
|
| 800845 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies |
2022-02-01 |
10.1136/jitc-2021-003655 |
Lutz Martina Svenja, Klimovich Boris, Maurer Stefanie, Heitmann Jonas S, Märklin Melanie, Zekri Latifa, Jung Gundram, Salih Helmut R, Hinterleitner Clemens |
| 800844 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer |
2022-02-01 |
10.1136/jitc-2021-003554corr1 |
|
| 800843 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers |
2022-02-01 |
10.1136/jitc-2021-004001 |
Fucà Giovanni, Cohen Romain, Lonardi Sara, Shitara Kohei, Elez Maria Elena, Fakih Marwan, Chao Joseph, Klempner Samuel J, Emmett Matthew, Jayachandran Priya, Bergamo Francesca, García Marc Díez, Mazzoli Giacomo, Provenzano Leonardo, Colle Raphael, Svrcek Magali, Ambrosini Margherita, Randon Giovanni, Shah Aakash Tushar, Salati Massimiliano, Fenocchio Elisabetta, Salvatore Lisa, Chida Keigo, Kawazoe Akihito, Conca Veronica, Curigliano Giuseppe, Corti Francesca, Cremolini Chiara, Overman Michael, Andre Thierry, Pietrantonio Filippo |
| 800842 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study) |
2022-02-01 |
10.1136/jitc-2021-004025 |
Seto Takashi, Nosaki Kaname, Shimokawa Mototsugu, Toyozawa Ryo, Sugawara Shunichi, Hayashi Hidetoshi, Murakami Haruyasu, Kato Terufumi, Niho Seiji, Saka Hideo, Oki Masahide, Yoshioka Hiroshige, Okamoto Isamu, Daga Haruko, Azuma Koichi, Tanaka Hiroshi, Nishino Kazumi, Tohnai Rie, Yamamoto Nobuyuki, Nakagawa Kazuhiko |
| 800841 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes |
2022-02-01 |
10.1136/jitc-2021-003082 |
Shah Parin, Forget Marie-Andrée, Frank Meredith L, Jiang Peixin, Sakellariou-Thompson Donastas, Federico Lorenzo, Khairullah Roohussaba, Neutzler Chantal Alexia, Wistuba Ignacio, Chow Chi-Wan B, Long Yan, Fujimoto Junya, Lin Shiaw-Yih, Maitra Anirban, Negrao Marcelo V, Mitchell Kyle Gregory, Weissferdt Annikka, Vaporciyan Ara A, Cascone Tina, Roth Jack A, Zhang Jianjun, Sepesi Boris, Gibbons Don L, Heymach John V, Haymaker Cara L, McGrail Daniel J, Reuben Alexandre, Bernatchez Chantale |
| 800840 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis |
2022-02-01 |
10.1136/jitc-2021-004036 |
Li Siming, Wu Xiaowen, Yan Xieqiao, Zhou Li, Chi Zhihong, Si Lu, Cui Chuanliang, Tang Bixia, Mao Lili, Lian Bin, Wang Xuan, Bai Xue, Dai Jie, Kong Yan, Tang Xiongwen, Feng Hui, Yao Sheng, Flaherty Keith T, Guo Jun, Sheng Xinan |
| 800839 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer |
2022-02-01 |
10.1136/jitc-2021-003490 |
Liikanen Ilkka, Basnet Saru, Quixabeira Dafne C A, Taipale Kristian, Hemminki Otto, Oksanen Minna, Kankainen Matti, Juhila Juuso, Kanerva Anna, Joensuu Timo, Tähtinen Siri, Hemminki Akseli |
